79289628
Apr 9, 2020
Nov 17, 2020
FRESENIUS KABI DEUTSCHLAND GMBH
Active Trademark
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, as well as for the treatment of CAR T-cell induced cytokine release syndrome
Pharmaceuticals